295 related articles for article (PubMed ID: 23064404)
21. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
22. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.
Marshall JR; Tangen CM; Sakr WA; Wood DP; Berry DL; Klein EA; Lippman SM; Parnes HL; Alberts DS; Jarrard DF; Lee WR; Gaziano JM; Crawford ED; Ely B; Ray M; Davis W; Minasian LM; Thompson IM
Cancer Prev Res (Phila); 2011 Nov; 4(11):1761-9. PubMed ID: 21896650
[TBL] [Abstract][Full Text] [Related]
23. Selenium and Vitamin E Cancer Prevention Trial: a nutrient approach to prostate cancer prevention.
Dunn BK; Ryan A; Ford LG
Recent Results Cancer Res; 2009; 181():183-93. PubMed ID: 19213568
[TBL] [Abstract][Full Text] [Related]
24. Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia.
Marshall JR; Sakr W; Wood D; Berry D; Tangen C; Parker F; Thompson I; Lippman SM; Lieberman R; Alberts D; Jarrard D; Coltman C; Greenwald P; Minasian L; Crawford ED
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1479-84. PubMed ID: 16896036
[TBL] [Abstract][Full Text] [Related]
25. Selenium and vitamin E supplements for prostate cancer: evidence or embellishment?
Moyad MA
Urology; 2002 Apr; 59(4 Suppl 1):9-19. PubMed ID: 11937432
[TBL] [Abstract][Full Text] [Related]
26. The selenium and vitamin E cancer prevention trial.
Klein EA; Lippman SM; Thompson IM; Goodman PJ; Albanes D; Taylor PR; Coltman C
World J Urol; 2003 May; 21(1):21-7. PubMed ID: 12756490
[TBL] [Abstract][Full Text] [Related]
27. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.
Gohagan JK; Prorok PC; Hayes RB; Kramer BS;
Control Clin Trials; 2000 Dec; 21(6 Suppl):251S-272S. PubMed ID: 11189683
[TBL] [Abstract][Full Text] [Related]
28. Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial.
Pak RW; Lanteri VJ; Scheuch JR; Sawczuk IS
Integr Cancer Ther; 2002 Dec; 1(4):338-44. PubMed ID: 14664728
[TBL] [Abstract][Full Text] [Related]
29. Colorectal Adenomas in Participants of the SELECT Randomized Trial of Selenium and Vitamin E for Prostate Cancer Prevention.
Lance P; Alberts DS; Thompson PA; Fales L; Wang F; San Jose J; Jacobs ET; Goodman PJ; Darke AK; Yee M; Minasian L; Thompson IM; Roe DJ
Cancer Prev Res (Phila); 2017 Jan; 10(1):45-54. PubMed ID: 27777235
[TBL] [Abstract][Full Text] [Related]
30. The Outcome of Selenium and Vitamin E Cancer Prevention Trial (SELECT) reveals the need for better understanding of selenium biology.
Hatfield DL; Gladyshev VN
Mol Interv; 2009 Feb; 9(1):18-21. PubMed ID: 19299660
[TBL] [Abstract][Full Text] [Related]
31. A nutrient approach to prostate cancer prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Dunn BK; Richmond ES; Minasian LM; Ryan AM; Ford LG
Nutr Cancer; 2010; 62(7):896-918. PubMed ID: 20924966
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention: a meta-analysis of randomized controlled trials.
Jiang L; Yang KH; Tian JH; Guan QL; Yao N; Cao N; Mi DH; Wu J; Ma B; Yang SH
Nutr Cancer; 2010; 62(6):719-27. PubMed ID: 20661819
[TBL] [Abstract][Full Text] [Related]
33. Impact of supplemental site grants to increase African American accrual for the Selenium and Vitamin E Cancer Prevention Trial.
Cook ED; Arnold KB; Hermos JA; McCaskill-Stevens W; Moody-Thomas S; Probstfield JL; Hamilton SJ; Campbell RD; Anderson KB; Minasian LM
Clin Trials; 2010 Feb; 7(1):90-9. PubMed ID: 20156960
[TBL] [Abstract][Full Text] [Related]
34. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk.
Kirsh VA; Hayes RB; Mayne ST; Chatterjee N; Subar AF; Dixon LB; Albanes D; Andriole GL; Urban DA; Peters U;
J Natl Cancer Inst; 2006 Feb; 98(4):245-54. PubMed ID: 16478743
[TBL] [Abstract][Full Text] [Related]
35. Clinical models for testing chemopreventative agents in prostate cancer and overview of SELECT: the Selenium and Vitamin E Cancer Prevention Trial.
Klein EA
Recent Results Cancer Res; 2003; 163():212-25; discussion 264-6. PubMed ID: 12903856
[TBL] [Abstract][Full Text] [Related]
36. Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study.
Stratton MS; Reid ME; Schwartzberg G; Minter FE; Monroe BK; Alberts DS; Marshall JR; Ahmann FR
Anticancer Drugs; 2003 Sep; 14(8):589-94. PubMed ID: 14501380
[TBL] [Abstract][Full Text] [Related]
37. Selenium and vitamin E for prostate cancer: post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status.
Ledesma MC; Jung-Hynes B; Schmit TL; Kumar R; Mukhtar H; Ahmad N
Mol Med; 2011; 17(1-2):134-43. PubMed ID: 20882260
[TBL] [Abstract][Full Text] [Related]
38. The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study.
Hartman TJ; Albanes D; Pietinen P; Hartman AM; Rautalahti M; Tangrea JA; Taylor PR
Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):335-40. PubMed ID: 9568790
[TBL] [Abstract][Full Text] [Related]
39. Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
Brasky TM; Darke AK; Song X; Tangen CM; Goodman PJ; Thompson IM; Meyskens FL; Goodman GE; Minasian LM; Parnes HL; Klein EA; Kristal AR
J Natl Cancer Inst; 2013 Aug; 105(15):1132-41. PubMed ID: 23843441
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
